STIs Part III: Gonorrhea and Chlamydia
CEimpact Podcast
English - June 06, 2022 09:00 - 30 minutes - 20.8 MBCourses Education Science ceimpact podcast precept2practice level up gamechangers pharmacy cme cpe pharmacology ceimpact geoff wall Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything by HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice.
The GameChanger
A 7-day course of doxycycline in the treatment of urogenital chlamydia is preferred and has been shown to be more efficacious compared to azithromycin. Ceftriaxone should be the treatment of choice for gonorrhea as there have been no “resistance”-related treatment failures identified in the United States at any anatomical site.
Show Segments
00:00 – Introduction
01:45 – STI Guidelines
02:34 – Chlamydia
14:56 – Gonorrhea
28:57 – Closing Remarks
Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
All relevant financial relationships have been mitigated.
References and Resources
CDC Sexually Transmitted Infections Treatment Guidelines, 2021
Redeem your CPE or CME
CPE (Pharmacist)CME (Physicians)Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membershipPrescribers: Get a membershipCE Information
Learning Objectives
Describe the treatment of Neisseria gonorrhea based on the 2021 recommendationsDiscuss pharmacotherapy options for patients with chlamydia with or without concomitant gonorrhea infections0.05 CEU/0.5 Hr
UAN: 0107-0000-22-224-H01-P
Initial release date: 06/062022
Expiration date: 06/06/2023
Additional CPE and CME details can be found here.